Inactivating PSMB5 mutations and P-glycoprotein (MDR1/ ABCB1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno) proteasome inhibitors in mononuclear blood cells from rheumatoid arthritis patients

C.S.E. Verbrugge, Y.G. Assaraf, B.A.C. Dijkmans, G.L. Scheffer, M.C.M. Al, D. den Uyl, R. Oerlemans, E.T. Chan, C.J. Kirk, G.J. Peters, J.W. van der Heijden, T.D. de Gruijl, R.J. Scheper, G. Jansen

Research output: Contribution to journalArticleAcademicpeer-review

84 Citations (Scopus)

Cite this